# Junta clínica — PT-pseudo_fc6cf5262222 (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_fc6cf5262222",
  "pid": "PT-pseudo_fc6cf5262222",
  "task": 1,
  "psa": 7.5,
  "age": 61,
  "months": 1,
  "pirads": "4",
  "psad": 0.179,
  "psav": 1.49,
  "psap": 4.6,
  "vol": 42.0,
  "dre": "Normal",
  "bx": "Positive",
  "cspca": 0.0,
  "medhx": "Hypertension",
  "meds": "valsartan, metoprolol",
  "notes": "PSA 7.5 ng/mL. PI-RADS 4. PSAD 0.18. Prostate volume 42 mL. csPCa 0.00.",
  "pmhx": [
    "Hypertension"
  ],
  "allergies": [],
  "vitals": {
    "weight": "79 kg",
    "height": "177 cm",
    "bmi": "25.2",
    "bp": "124/76 mmHg",
    "hr": "83 bpm",
    "smoking": "Ex-smoker (34 pack-yr, quit 2006)",
    "last_dental": "3 yr ago",
    "flu_vax": "Sep 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "22 Feb 2025",
  "enc_ref": "Dr. R. Visser (GP)",
  "enc_type": "Re-evaluation - prior PCa diagnosis",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Clinical reassessment triggered by a recent PSA rise to 7.5 ng/mL and a previous biopsy bucket marked positive."
    },
    {
      "s": "History",
      "t": "A 61-year-old self-employed contractor specializing in carpentry has remained under urological observation since his initial screening in 2022. He reports an IPSS score of 2 out of 35, indicating minimal lower urinary tract symptoms, and maintains a daily 45-minute walking regimen. Alcohol consumption averages six units weekly. An ex-smoker with a 34 pack-year history who ceased tobacco use in 2006, he currently lives independently while his wife resides elsewhere and their adult son checks in regularly. Hypertension is managed with valsartan and metoprolol. A recent vascular surgery consultation addressed asymptomatic varicose veins. He denies bone pain, haematuria, or unexplained weight loss, and his surgical background includes only a minor arthroscopic knee procedure performed more than ten years ago."
    },
    {
      "s": "Physical examination",
      "t": "DRE — texture: smooth and symmetric; mobility: unremarkable; asymmetry: absent.\nGeneral assessment shows stable vital signs, including a blood pressure of 124/76 mmHg and a regular pulse at 83 beats per minute. Abdominal palpation yields no detectable masses or organ enlargement."
    }
  ],
  "occupation": "self-employed contractor (carpentry)",
  "marital": "Married",
  "living": "Lives alone; adult son nearby",
  "next_of_kin": "Spouse / partner (primary contact)",
  "recent_other": [
    "Vascular surgery — varicose veins consult"
  ],
  "alcohol": "6 units / week",
  "exercise": "Walking 45 min/day",
  "ipss": "IPSS score: 2/35 (mild LUTS)",
  "admin": "Patient anxious about procedures — allocate extra consult time.",
  "mri_hospital": "Erasmus MC",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_fc6cf5262222
Task: 1

Encounter: Urology - outpatient on 22 Feb 2025.
Referrer: Dr. R. Visser (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 61-year-old male
  - PSA: 7.5 ng/mL
  - mpMRI — PI-RADS score: 4 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.179 ng/mL²
  - PSA velocity: 1.49 ng/mL/yr
  - Prior PSA: 4.6 ng/mL
  - Prostate volume: 42.0 mL
  - Months since last PSA: 1
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.0 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Hypertension
  - Problem list / PMHx: Hypertension
  - Current medication: valsartan, metoprolol
  - Allergies: NKA
  - Additional notes: PSA 7.5 ng/mL. PI-RADS 4. PSAD 0.18. Prostate volume 42 mL. csPCa 0.00.

Vitals: weight 79 kg, height 177 cm, BMI 25.2, BP 124/76 mmHg, HR 83 bpm. Smoking: Ex-smoker (34 pack-yr, quit 2006).

Chief complaint: Clinical reassessment triggered by a recent PSA rise to 7.5 ng/mL and a previous biopsy bucket marked positive.

History: A 61-year-old self-employed contractor specializing in carpentry has remained under urological observation since his initial screening in 2022. He reports an IPSS score of 2 out of 35, indicating minimal lower urinary tract symptoms, and maintains a daily 45-minute walking regimen. Alcohol consumption averages six units weekly. An ex-smoker with a 34 pack-year history who ceased tobacco use in 2006, he currently lives independently while his wife resides elsewhere and their adult son checks in regularly. Hypertension is managed with valsartan and metoprolol. A recent vascular surgery consultation addressed asymptomatic varicose veins. He denies bone pain, haematuria, or unexplained weight loss, and his surgical background includes only a minor arthroscopic knee procedure performed more than ten years ago.

Physical examination: DRE — texture: smooth and symmetric; mobility: unremarkable; asymmetry: absent.
General assessment shows stable vital signs, including a blood pressure of 124/76 mmHg and a regular pulse at 83 beats per minute. Abdominal palpation yields no detectable masses or organ enlargement.

Patient info: self-employed contractor (carpentry); Married; Lives alone; adult son nearby.
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 6 units / week; exercise Walking 45 min/day; IPSS score: 2/35 (mild LUTS).

Recent other appointments: Vascular surgery — varicose veins consult.
Admin: Patient anxious about procedures — allocate extra consult time.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: NO BIOPSY   p(biopsy) = 0.42
  uncertainty  +/- 0.11 epistemic (95% band 0.20-0.64); among patients I cannot tell apart the outcome was 0.98 of 1.00 mixed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = 1 on the problem list (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 61 (2% of my signal; from age) · DRE = Normal (10% of my signal; from dre_suspicious) · PSA = 7.5 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 42 mL (1% of my signal; from log_vol, vol) · PSA density = 0.179 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.00 (1% of my signal; from cspca) · PI-RADS = 4 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior positive biopsy. The panel alone does not answer, and that is the finding.

The criterion here is that the visible panel does not determine this decision: he already has a tissue diagnosis, so neither a high PI-RADS nor a rising PSA is new information. What decides it is the documented grade of the prior biopsy and the surveillance history, which live in the previous notes. Measured on the labelled series: none of the three panel
rules I carry for this situation (PSA >= 20, age >= 78, PI-RADS <= 2) applies to him, and among the
39 remaining labelled men in this situation no structured variable separates the two answers.

REGISTRAR: the previous notes are where this case is decided. Read them for the grade of the prior
biopsy (Gleason or ISUP), the number of biopsy sessions and their dates, and whether he is on a
surveillance protocol with a confirmatory biopsy due. Do not read this as 'defer' and do not read it
as 'biopsy'.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  important  prior biopsy = Positive
  noted      age = 61 · DRE = Normal · PSA = 7.5 ng/mL · prostate volume = 42 mL · PSA density = 0.179 · PI-RADS = 4 · comorbidity = 1 on the problem list
  not used   family history, csPCa probability
CONFIDENCE: uncertain — none of my three panel rules applies; the fact that would settle it — the documented prior grade — lives in the notes, not on the panel

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 49 labelled men in this same situation (Positive prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 1.57: PI-RADS 4, PSA 8.4, PSAD 0.1, age 63, DRE Normal -> BIOPSY (uncertain). He wrote: "Patient on Active surveillance. Initial ISUP and MRI is needed."
  2. distance 1.94: PI-RADS 4, PSA 5.2, PSAD 0.151, age 68, DRE Normal -> BIOPSY (uncertain). He wrote: "Again missing earlier ISUP grading and if the PIRADS 4 lesion is stabile or growing"
  3. distance 2.19: PI-RADS 4, PSA 5.3, PSAD 0.1, age 56, DRE Nodus -> BIOPSY (clear). He wrote: "PIRADS 4 in a young man with a rapid increasing PSA"

PRECEDENT: BIOPSY (weighted vote 1.00 for biopsy). Distance-weighted precedent is no better than chance here (0.47 leave-one-out): read the precedents for how this urologist reasons, not for the answer.

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  important  prior biopsy = Positive · PSA = 7.5 ng/mL · PI-RADS = 4
  noted      family history = not opened (0 of 91) · age = 61 · DRE = Normal · prostate volume = 42 mL · PSA density = 0.179
  not used   csPCa probability, comorbidity
CONFIDENCE: uncertain — in this situation the library is no better than chance (47% out of fold)

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 49 labelled traces in this situation (Positive prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  decisive   prior biopsy = Positive
  important  age = 61 · PSA = 7.5 ng/mL · PI-RADS = 4
  noted      family history = not opened (0 of 91) · DRE = Normal · prostate volume = 42 mL · PSA density = 0.179 · comorbidity = 1 on the problem list
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The retrieved guideline discusses using PI-RADS thresholds to guide biopsy decisions, noting that a threshold of PI-RADS $\ge 3$ is used to trigger biopsy, and that increasing the threshold to $\ge 4$ could avoid a significant number of biopsies while missing some cancer.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, I note that the guideline suggests a PI-RADS threshold of $\ge 3$ for biopsy, whereas EXPERT-STRUCTURED marked PI-RADS 4 as decisive. The guideline treats the PI-RADS score as a factor in a risk-adapted matrix, whereas EXPERT-STRUCTURED marked it decisive based on its weight in the panel. EXPERT-COHORT marks the prior biopsy as important, which the guideline treats as context, whereas the guideline focuses on the PI-RADS score as a primary determinant in its risk stratification.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the documented grade of the prior biopsy: at ISUP 2 or above the guideline sends him to treatment, not to more tissue; if it is unrecorded the indication stands
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case hinges on the documented grade of the prior biopsy and the surveillance plan detailed in the previous notes, as the panel alone is inconclusive.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Does the lesion in the MRI report show change when compared against an earlier study?
  psa_trend (get_psa_trend) -> What is the trend of the serial PSA values?
  previous_notes (get_previous_notes) -> What is the documented grade of the prior biopsy, and is there a surveillance protocol with a confirmatory biopsy due?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the documented grade of the prior biopsy?
  Q2. Is the lesion in the radiology_report compared against an earlier study?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
The lesion in the MRI report shows early focal enhancement compared to adjacent tissue.
psa_trend
The trend of the serial PSA values is a rising trajectory: PSA 2.9 (Nov 2022) rising to 7.5 (Feb 2025).
previous_notes
The documented grade of the prior biopsy is not explicitly stated, and there is no mention of a surveillance protocol with a confirmatory biopsy due.

WHAT I DID NOT OPEN
family-history anamnesis, as it was not listed in the plan and could not have changed the answer.

WHAT THIS SUPPORTS
FOR sampling this patient now
The rising PSA trend (PSA 2.9 to 7.5 ng/mL) suggests progression.
The PI-RADS 4 finding in the right peripheral zone mid-gland is concerning.
AGAINST sampling this patient now
The documented grade of the prior biopsy is not explicitly stated, leaving the clinical context unknown.
There is no mention of a surveillance protocol with a confirmatory biopsy due in the notes.

WHERE THIS LEANS
LEAN: biopsy

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 7.50 ng/mL over 4 points spanning 27 months; velocity +2.04 ng/mL per year; doubling time about 20 months.
PROJECTION at 6 months: 10.3 ng/mL, conformal 95% band 3.0-36.1.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 7.5 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: borderline — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report — the laboratory panel was not opened, so that block is imputed and my band is wider for it; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.57
  uncertainty  +/- 0.11 epistemic (95% band 0.36-0.77), of which 0.01 comes from values that had to be imputed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 59% of the time over the 29 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 4 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      PSA = 7.5 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 42 mL (4% of my signal; from log_vol, vol) · PSA density = 0.179 (0% of my signal; from psad_calc) · comorbidity = 1 on the problem list (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, DRE, csPCa probability
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 59% of the time over the 29 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  DEFER, p(biopsy)=0.42  ('discuss' tier; weight 1.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.57  ('discuss' tier, fusion_nolab; weight 1.5)
  EXPERT-LIBRARY     BIOPSY, p(biopsy)=1.00  (k=3 precedents; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: weighted vote of the trained experts, p = 0.51 — carried by weighted panel.
PANEL ANSWER: BIOPSY. EXPERT-FUSION carried the most weight ('discuss' tier, fusion_nolab). In this bucket no rule applied and the documents did not record the prior grade, so the trained experts decide.
Dissenting on the board: EXPERT-STRUCTURED. Their bids are recorded above; they did not carry because a higher rung of the protocol applied.

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           Positive                     E1:DEC E3:DEC cohort:IMP library:IMP E2:—            -> decisive
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:not E2:—                  -> not_used (raised from noted by the board)
  age          61                           E1:not E3:— cohort:not library:not E2:—              -> important
  dre          Normal                       E1:not E3:— cohort:not library:not E2:—              -> not_used (raised from noted by the board)
  psa          7.5 ng/mL                    E1:not E3:not cohort:not library:IMP E2:not          -> important
  vol          42 mL                        E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.179                        E1:not E3:not cohort:not library:not E2:—            -> noted
  cspca        0.00                         E1:not E3:— cohort:— library:— E2:—                  -> not_used
  pirads       4                            E1:not E3:IMP cohort:not library:IMP E2:—            -> important
  comorbidity  1 on the problem list        E1:IMP E3:not cohort:not library:— E2:—              -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: uncertain.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened (radiology_report, psa_trend, previous_notes) have addressed the moderator's questions to some extent. The `previous_notes` explicitly state that the documented grade of the prior biopsy is not explicitly stated, and there is no mention of a surveillance protocol. The `radiology_report` addresses the second question by stating the lesion shows early focal enhancement compared to adjacent tissue, which implies a comparison, but does not explicitly state if it is compared against an earlier study.

ALIGNMENT WITH THE PANEL
The retrieved evidence does not directly confirm or refute the PANEL-PROTOCOL's answer of BIOPSY, as the critical piece of information—the documented prior biopsy grade—remains unstated in the notes. The rising PSA trend supports the leaning towards biopsy, but the lack of information on the prior biopsy grade leaves the decision point unresolved according to the protocol's stated dependency.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the documented grade of the prior biopsy? Answered by the registrar: "The documented grade of the prior biopsy is not explicitly stated."
Q2. Is the lesion in the radiology_report compared against an earlier study? Answered by the registrar: The report shows "early focal enhancement compared to adjacent tissue," which is suggestive but not a direct answer to the comparison question.

WHAT CARRIES WEIGHT, AND WHY
<prior biopsy>: not_used / noted with the value "not explicitly stated" because the registrar could not retrieve the documented grade, which is the key variable the cohort criterion stated would decide the case. I would move this to 'decisive' if the rising PSA trend was deemed more important than the missing prior grade. My confidence in the record as it stands is borderline because the critical piece of information required by the protocol is missing.

MY SUGGESTION TO THE CHAIR
Given that the panel protocol's decision rests on the documented prior grade, and the registrar could not retrieve it, the record is not in a state to be decided by the protocol's explicit rules. I suggest deferral pending clarification on the prior biopsy grade.

VERDICT: not-ready | SUGGEST: defer | MISSING: none

[The conference closes after pass 1: every document on the plan is open; nothing outside the plan is ever opened. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: uncertain)

PI-RADS 4, PSA 7.5, and rising trend suggest further tissue sampling is warranted. Prior biopsy grade is not recorded, which is a key missing fact. The uncertainty regarding prior pathology dictates sampling to determine management pathway. Consider confirmatory biopsy.

What carried weight: bx=decisive, age=important, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes
